Suppr超能文献

一项关于复杂恶性肝门部胆管狭窄的多枚金属支架的 17 年回顾性研究:闭塞金属支架再干预的生存、支架通畅率和结局。

A 17 years retrospective study on multiple metal stents for complex malignant hilar biliary strictures: Survival, stents patency and outcomes of re-interventions for occluded metal stents.

机构信息

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Digestive Endoscopy Unit, Rome, Italy; Catholic University, Centre for Endoscopic Research therapeutics and Training (CERTT), Rome, Italy.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Digestive Endoscopy Unit, Rome, Italy; Catholic University, Centre for Endoscopic Research therapeutics and Training (CERTT), Rome, Italy.

出版信息

Dig Liver Dis. 2019 Sep;51(9):1287-1293. doi: 10.1016/j.dld.2019.03.032. Epub 2019 Apr 26.

Abstract

BACKGROUND

Endoscopic placement of SEMSs for malignant hilar biliary strictures (MHBS) is well-established palliative treatment for inoperable patients. Objectives of this study were evaluation of survival and stents patency after placement of multiple SEMS for palliation of complex MHBS.

METHODS

Retrospective review of patients with MHBS that underwent ERCP with insertion of multiple SEMSs for palliation. Survival-associated factors and stents patency were analyzed by Cox multivariate analysis.

RESULTS

Between January 1998 and January 2015, 740 patients with nonoperable MHBS that underwent ERCP were identified and only 18.2% of these received multiple SEMSs. Complications were observed in 7.5% of the patients with no procedure-related mortality. Palliative therapies (chemotherapy, external beam radiotherapy and high dose rate brachytherapy) were done in some patients, and outcomes were evaluated. Overall mean survival of the 134 patients was 323 days. Of these, 59% did not had stents malfunction while 41% patients had episodes of SEMSs malfunction and mean survival after re-interventions was 502.9 days. Survival was not influenced by type of tumor, sex or age.

CONCLUSIONS

Endoscopic multiple SEMSs placement is safe and effective in patients with complex MHBS. Survival is independent from the type and complexity of MHBS while is prolonged in patients undergoing HDR brachytherapy. Prompt recognition of SEMSs malfunction is fundamental for survival.

摘要

背景

内镜下放置 SEMS 治疗恶性肝门部胆管狭窄(MHBS)是无法手术患者的标准姑息性治疗方法。本研究的目的是评估多个 SEMS 放置治疗复杂 MHBS 的姑息效果的生存和支架通畅率。

方法

回顾性分析接受 ERCP 并插入多个 SEMS 以姑息治疗 MHBS 的患者。采用 Cox 多因素分析评估生存相关因素和支架通畅率。

结果

1998 年 1 月至 2015 年 1 月期间,共确定了 740 例无法手术的 MHBS 患者接受了 ERCP,其中只有 18.2%的患者接受了多个 SEMS 治疗。7.5%的患者出现并发症,但无与操作相关的死亡。对部分患者进行了姑息性治疗(化疗、外照射放疗和高剂量率近距离放疗),并评估了疗效。134 例患者的总体平均生存时间为 323 天。其中,59%的患者支架无故障,41%的患者支架出现故障,再次介入治疗后的平均生存时间为 502.9 天。生存与肿瘤类型、性别或年龄无关。

结论

内镜下多个 SEMS 放置术治疗复杂 MHBS 是安全有效的。生存与 MHBS 的类型和复杂性无关,而接受 HDR 近距离放疗的患者生存时间延长。及时发现 SEMS 故障对于生存至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验